Walleye Trading’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.9M | Buy |
378,650
+36,143
| +11% | +$1.71M | 0.02% | 643 |
|
|
2025
Q4 | $17.4M | Sell |
342,507
-209,153
| -38% | -$10.7M | 0.02% | 678 |
|
|
2025
Q3 | $30.6M | Buy |
551,660
+482,185
| +694% | +$28.2M | 0.05% | 420 |
|
|
2025
Q2 | $4.8M | Sell |
69,475
-101,941
| -59% | -$6.93M | 0.01% | 1235 |
|
|
2025
Q1 | $11.9M | Buy |
171,416
+132,838
| +344% | +$11M | 0.03% | 634 |
|
|
2024
Q4 | $3.32M | Sell |
38,578
-256,781
| -87% | -$27.8M | 0.01% | 1402 |
|
|
2024
Q3 | $35.2M | Sell |
295,359
-72,343
| -20% | -$9.65M | 0.07% | 278 |
|
|
2024
Q2 | $52.5M | Buy |
367,702
+76,065
| +26% | +$10.1M | 0.12% | 153 |
|
|
2024
Q1 | $37.4M | Buy |
291,637
+18,530
| +7% | +$2.21M | 0.08% | 234 |
|
|
2023
Q4 | $28.3M | Sell |
273,107
-37,009
| -12% | -$3.66M | 0.06% | 318 |
|
|
2023
Q3 | $28.2M | Buy |
+310,116
| New | +$27.3M | 0.07% | 258 |
|
|
2020
Q3 | – | Sell |
-23,206
| Closed | -$774K | – | 4464 |
|
|
2020
Q2 | $760K | Buy |
+23,206
| New | +$741K | ﹤0.01% | 1896 |
|
|
2019
Q1 | – | Sell |
-17,166
| Closed | -$422K | – | 4597 |
|
|
2018
Q4 | $395K | Buy |
17,166
+828
| +5% | +$18.4K | ﹤0.01% | 2724 |
|
|
2018
Q3 | $385K | Sell |
16,338
-74,260
| -82% | -$1.81M | ﹤0.01% | 3161 |
|
|
2018
Q2 | $2.09M | Buy |
90,598
+76,190
| +529% | +$1.81M | 0.01% | 1303 |
|
|
2018
Q1 | $355K | Buy |
+14,408
| New | +$378K | ﹤0.01% | 2998 |
|
|
2017
Q2 | – | Sell |
-9,074
| Closed | -$183K | – | 4813 |
|
|
2017
Q1 | $156 | Sell |
9,074
-33,456
| -79% | -$583K | ﹤0.01% | 3133 |
|
|
2016
Q4 | $763K | Sell |
42,530
-82,420
| -66% | -$1.49M | 0.01% | 1742 |
|
|
2016
Q3 | $2.6M | Buy |
+124,950
| New | +$3.1M | 0.02% | 794 |
|
|
2016
Q2 | – | Sell |
-24,390
| Closed | -$669K | – | 5609 |
|
|
2016
Q1 | $661K | Buy |
+24,390
| New | +$653K | 0.01% | 1730 |
|
|
2015
Q3 | – | Sell |
-13,038
| Closed | -$369K | – | 5349 |
|
|
2015
Q2 | $357K | Buy |
+13,038
| New | +$367K | ﹤0.01% | 1965 |
|
|
2015
Q1 | – | Sell |
-3,330
| Closed | -$76.7K | – | 4350 |
|
|
2014
Q4 | $70K | Buy |
3,330
+516
| +18% | +$11.5K | ﹤0.01% | 3029 |
|
|
2014
Q3 | $67K | Buy |
+2,814
| New | +$64.8K | ﹤0.01% | 2924 |
|
|
2014
Q1 | – | Sell |
-2,790
| Closed | -$59.4K | – | 3804 |
|
|
2013
Q4 | $52K | Buy |
2,790
+790
| +40% | +$13.8K | ﹤0.01% | 2816 |
|
|
2013
Q3 | $34K | Buy |
2,000
+1,060
| +113% | +$17.8K | ﹤0.01% | 2401 |
|
|
2013
Q2 | $15K | Buy |
+940
| New | +$15.6K | ﹤0.01% | 2591 |
|
Other funds holding NVO
DAM
F
Walleye Trading's NVO Position: Q1 2026 in Review
Walleye Trading increased its Novo Nordisk (NVO) stake by 11% in Q1 2026, buying an estimated $1.71M and bringing the position to 378,650 shares worth $13.9M. The position accounts for 0.02% of the portfolio, ranked #643.
Walleye Trading first reported a position in NVO in Q2 2013 and has held it in 26 quarters since. The position peaked at $52.5M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Walleye Trading held 378,650 shares of Novo Nordisk worth $13.9M as of Q1 2026.
- Walleye Trading bought 36,143 Novo Nordisk shares in Q1 2026, an estimated $1.71M.
- Novo Nordisk made up 0.02% of Walleye Trading's portfolio in Q1 2026, its #643 holding.
- Walleye Trading first reported a position in Novo Nordisk in Q2 2013 and has held it in 26 quarters since.
- Walleye Trading's Novo Nordisk position peaked at $52.5M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.